BenzingaAugust 18, 2026 at 5:58 AM NY17 days ago
UBS Maintains Neutral on Corteva, Lowers Price Target to $85
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $89 to $85.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga
Companies in This Story
Related Stories
Which dow jones stocks are moving on Friday?
ChartMill3 hours ago
Exploring the top movers within the S&P500 index during today's session.
ChartMill3 hours ago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo3 hours ago
Sector Update: Financial
Yahoo4 hours ago
Should You Buy, Sell or Hold PVH Stock Post Q2 Earnings?
Yahoo5 hours ago